ArticleFrontiers in neurology2020

Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study.

Bianca Raffaelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.